药物使用 p53:障碍,标准和前景
Huaxin Song1, Shujun Xiao1, Jiaqi Wu1
1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Cancer discovery
|November 1, 2024
概括
恢复瘤抑制剂p53蛋白的功能,而不是抑制它,为癌症治疗提供了一个新的策略. 本研究确定了障碍,并提出了开发有效突变p53救援化合物的标准.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 瘤抑制剂p53是人类癌症中最常发生突变的蛋白质.
- 传统的药物策略侧重于抑制,但p53突变往往导致功能丧失,需要恢复.
- 向突变p53一直是癌症药物治疗中的重大挑战.
研究的目的:
- 重新评估科学逻辑并解决围绕p53功能恢复策略的误解.
- 确定阻碍开发针对突变p53.3的药物的关键障碍.
- 提出评估突变p53救援化合物的有效性和临床转化标准.
主要方法:
- 文献审查和对p53向现有科学方法的批判性分析.
- 识别和分类的障碍,以药物治疗突变p53.
- 开发一个评估潜在p53救援化合物的框架.
主要成果:
- 确定了阻碍突变p53疗法的发展的四个主要障碍.
- 在p53研究领域挑战现有的范式和误解.
- 建议新的标准来评估p53恢复剂的疗效和临床可行性.
结论:
- 功能恢复策略对于药理上准突变p53.3是必不可少的.
- 克服已识别的障碍对于推进突变p53救援化合物开发至关重要.
- 拟议的评估标准和规范将指导未来的研究和临床翻译工作.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K


